IBMC is home to a highly collaborative group of scientists and medical doctors who work on solving fundamental questions in the fields of omics and oncology for the advancement of diagnostics and therapeutics.
IBMC has set up a dozen of research centers/labs, including Aptamer Selection Center, New Medicine and Targeted Treatment Center, Intelligent Diagnosis Center, Upper Gastrointestinal Tumor Diagnosis & Treatment Center, and Joint ECMO R&D Center. In academic research, the big-team breakthrough mode based on major projects and led by academicians and leading talents is adopted, and a batch of initial achievements have been scored in fast nucleic acid diagnosis of COVID-19, ECMO equipment and targeted tumor treatment, and heavy ion R&D for cancer treatment. In the construction of coordinated and innovative system of industry, university, research and hospital, the Institute has established close cooperation with medical institutions such as Cancer Hospital of the University of Chinese Academy of Sciences, University of Macau, and Institute of Chemistry Chinese Academy of Sciences, as well as leading enterprises such as Ustar and Cobetter in Hangzhou.